TrialJournal of viral hepatitis2019

Efficacy and safety of ombitasvir/paritaprevir/ritonavir and dasabuvir with low-dose ribavirin in patients with chronic hepatitis C virus genotype 1a infection without cirrhosis.

Fred Poordad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.